A report was received on 26 oct 2020 from the home therapy nurse (htn) of a (b)(6) year old female with significant comorbidities including end stage renal disease, stating the patient experienced an adverse event (nos) during their first in-center hemodialysis treatment with the nxstage system on (b)(6) 2020.Additional information was received on 02-13 nov 2020 from the htn stating the patient became symptomatic within minutes of initiating treatment.Symptoms included shortness of breath, hypertension, cyanosis, abnormal respirations, and unresponsiveness.Nasal oxygen was applied and emergency medical services were summoned.During transport to hospital, the patient became pulseless and cardiopulmonary resuscitation (cpr) measures were initiated.The patient received bag valve mask oxygenation and was in pulseless electrical activity upon arrival to the emergency room (er) where they were intubated.Cpr continued and included 9 doses of epinephrine, 1 amp of calcium, 1 gram of magnesium, and defibrillation x3.Following return of circulation, the patient received 1 amp of bicarb and 125 mg of solu-medrol.The patient was admitted to the intensive care unit on mechanical ventilation and was diagnosed with cardiopulmonary arrest and anoxic brain injury.The patient was extubated, transitioned into comfort care, and expired on (b)(6) 2020.
|